HIF-1α leads to changes in metabolic pathways as follows: the HIF-1α–PGD–PPP axis stimulates GIST cells from the G1 phase to the S phase, inhibits GIST cell apoptosis through metabolic reprogramming, and ultimately leads to IM resistance (Figure 1C) (47). This evidence concerns the gene HIF1A and gastrointestinal stromal tumor.